Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424. Bray F Ferlay J Soerjomataram I Siegel RL Torre LA Jemal A : Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J Clin 2018 ; 68 : 394 – 424 . 10.3322/caac.2149230207593 Search in Google Scholar

2. Budny A, Kozłowski P, Kamińska M, Jankiewicz M, Kolak A, Budny B et al.: [Epidemiology and risk factors of hepatocellular carcinoma]. Pol Merkur Lekarski 2017; 43: 133–139. Budny A Kozłowski P Kamińska M Jankiewicz M Kolak A Budny B : [Epidemiology and risk factors of hepatocellular carcinoma] . Pol Merkur Lekarski 2017 ; 43 : 133 – 139 . Search in Google Scholar

3. Jindal A, Thadi A, Shailubhai K: Hepatocellular carcinoma: etiology and current and future drugs. J Clin Exp Hepatol 2019; 9: 221–232. Jindal A Thadi A Shailubhai K : Hepatocellular carcinoma: etiology and current and future drugs . J Clin Exp Hepatol 2019 ; 9 : 221 – 232 . 10.1016/j.jceh.2019.01.004647712531024205 Search in Google Scholar

4. Fujiwara N, Friedman SL, Goossens N, Hoshida Y: Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol 2018; 68: 526–549. Fujiwara N Friedman SL Goossens N Hoshida Y : Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine . J Hepatol 2018 ; 68 : 526 – 549 . 10.1016/j.jhep.2017.09.016581831528989095 Search in Google Scholar

5. Society AC: Liver cancer risk factors 2019 [updated April 1, 2019. Online: https://www.cancer.org/cancer/liver-cancer/causes-risks-prevention/risk-factors.html]. Society AC : Liver cancer risk factors 2019 [updated April 1, 2019. Online: https://www.cancer.org/cancer/liver-cancer/causes-risks-prevention/risk-factors.html] . Search in Google Scholar

6. Shafizadeh N, Kakar S: Hepatocellular carcinoma: histologic subtypes. Surg Pathol Clin 2013; 6: 367–384. Shafizadeh N Kakar S : Hepatocellular carcinoma: histologic subtypes . Surg Pathol Clin 2013 ; 6 : 367 – 384 . 10.1016/j.path.2013.03.00726838979 Search in Google Scholar

7. El Jabbour T, Lagana SM, Lee H: Update on hepatocellular carcinoma: Pathologists’ review. World J Gastroenterol 2019; 25: 1653–1665. El Jabbour T Lagana SM Lee H : Update on hepatocellular carcinoma: Pathologists’ review . World J Gastroenterol 2019 ; 25 : 1653 – 1665 . 10.3748/wjg.v25.i14.1653646594331011252 Search in Google Scholar

8. Torbenson MS: Morphologic subtypes of hepatocellular carcinoma. Gastroenterol Clin North Am 2017; 46: 365–391. Torbenson MS : Morphologic subtypes of hepatocellular carcinoma . Gastroenterol Clin North Am 2017 ; 46 : 365 – 391 . 10.1016/j.gtc.2017.01.00928506370 Search in Google Scholar

9. Han YS, Choi DL, Park JB: Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation – eighteen months of followup: a case report. Transplant Proc 2008; 40: 2835–2836. Han YS Choi DL Park JB : Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation – eighteen months of followup: a case report . Transplant Proc 2008 ; 40 : 2835 – 2836 . 10.1016/j.transproceed.2008.07.01218929876 Search in Google Scholar

10. Okuda K, Noguchi T, Kubo Y, Shimokawa Y, Kojiro M, Nakashima T: A clinical and pathological study of diffuse type hepatocellular carcinoma. Liver 1981; 1: 280–289. Okuda K Noguchi T Kubo Y Shimokawa Y Kojiro M Nakashima T : A clinical and pathological study of diffuse type hepatocellular carcinoma . Liver 1981 ; 1 : 280 – 289 . 10.1111/j.1600-0676.1981.tb00044.x6294441 Search in Google Scholar

11. Kim YK, Han YM, Kim CS: Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol 2009; 70: 94–100. Kim YK Han YM Kim CS : Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI . Eur J Radiol 2009 ; 70 : 94 – 100 . 10.1016/j.ejrad.2008.01.01518316169 Search in Google Scholar

12. Rogoveanu I, Văcaru D, Gheonea D, Georgescu CV, Comănescu V, Ciurea T: Diagnostic particularities in primitive diffuse form hepatocellular carcinoma associated with portal vein thrombosis. Rom J Morphol Embryol 2005; 46: 317–321. Rogoveanu I Văcaru D Gheonea D Georgescu CV Comănescu V Ciurea T : Diagnostic particularities in primitive diffuse form hepatocellular carcinoma associated with portal vein thrombosis . Rom J Morphol Embryol 2005 ; 46 : 317 – 321 . Search in Google Scholar

13. Jakate S, Yabes A, Giusto D, Naini B, Lassman C, Yeh MM et al.: Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis. Am J Surg Pathol 2010; 34: 935–341. Jakate S Yabes A Giusto D Naini B Lassman C Yeh MM : Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis . Am J Surg Pathol 2010 ; 34 : 935 – 341 . 10.1097/PAS.0b013e3181ddf52f20463569 Search in Google Scholar

14. Ho CM, Liang PC, Hu RH, Lee PH: Diffuse cirrhosis-like recurrence of hepatocellular carcinoma after curative resection. Surgery 2016; 160: 519–520. Ho CM Liang PC Hu RH Lee PH : Diffuse cirrhosis-like recurrence of hepatocellular carcinoma after curative resection . Surgery 2016 ; 160 : 519 – 520 . 10.1016/j.surg.2015.12.007 Search in Google Scholar

15. Poddar N, Avezbakiyev B, He Z, Jiang M, Gohari A, Wang JC: Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis. J Gastrointest Cancer 2012; 43: 486–489. Poddar N Avezbakiyev B He Z Jiang M Gohari A Wang JC : Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis . J Gastrointest Cancer 2012 ; 43 : 486 – 489 . 10.1007/s12029-010-9235-z Search in Google Scholar

16. Trevisani F, Caraceni P, Bernardi M, D’Intino PE, Arienti V, Amorati P et al.: Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993; 72: 1557–1563. Trevisani F Caraceni P Bernardi M D’Intino PE Arienti V Amorati P : Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors . Cancer 1993 ; 72 : 1557 – 1563 . 10.1002/1097-0142(19930901)72:5<1557::AID-CNCR2820720512>3.0.CO;2-5 Search in Google Scholar

17. Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK: Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging 2003; 18: 189–195. Kanematsu M Semelka RC Leonardou P Mastropasqua M Lee JK : Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations . J Magn Reson Imaging 2003 ; 18 : 189 – 195 . 10.1002/jmri.10336 Search in Google Scholar

18. Reynolds AR, Furlan A, Fetzer DT, Sasatomi E, Borhani AA, Heller MT et al.: Infiltrative hepatocellular carcinoma: what radiologists need to know. Radiographics 2015; 35: 371–386. Reynolds AR Furlan A Fetzer DT Sasatomi E Borhani AA Heller MT : Infiltrative hepatocellular carcinoma: what radiologists need to know . Radiographics 2015 ; 35 : 371 – 386 . 10.1148/rg.352140114 Search in Google Scholar

19. Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR et al.: Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg 2011; 15: 2089–2097. Demirjian A Peng P Geschwind JF Cosgrove D Schutz J Kamel IR : Infiltrating hepatocellular carcinoma: seeing the tree through the forest . J Gastrointest Surg 2011 ; 15 : 2089 – 2097 . 10.1007/s11605-011-1614-7 Search in Google Scholar

20. Sereni CP, Rodgers SK, Kirby CL, Goykhman I: Portal vein thrombus and infiltrative HCC: a pictoral review. Abdom Radiol (NY) 2017; 42: 159–170. Sereni CP Rodgers SK Kirby CL Goykhman I : Portal vein thrombus and infiltrative HCC: a pictoral review . Abdom Radiol (NY) 2017 ; 42 : 159 – 170 . 10.1007/s00261-016-0855-z Search in Google Scholar

21. Benvegnù L, Noventa F, Bernardinello E, Pontisso P, Gatta A, Alberti A: Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut 2001; 48: 110–115. Benvegnù L Noventa F Bernardinello E Pontisso P Gatta A Alberti A : Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development . Gut 2001 ; 48 : 110 – 115 . 10.1136/gut.48.1.110 Search in Google Scholar

22. Myung SJ, Yoon JH, Kim KM, Gwak GY, Kim YJ, Yu JW et al.: Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments. Hepatogastroenterology 2006; 53: 266–270. Myung SJ Yoon JH Kim KM Gwak GY Kim YJ Yu JW : Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments . Hepatogastroenterology 2006 ; 53 : 266 – 270 . Search in Google Scholar

23. Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J et al.: Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol 2012; 19: 2897–2907. Kneuertz PJ Demirjian A Firoozmand A Corona-Villalobos C Bhagat N Herman J : Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes . Ann Surg Oncol 2012 ; 19 : 2897 – 2907 . 10.1245/s10434-012-2336-0 Search in Google Scholar

24. Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C et al.: Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 2006; 101: 524–532. Farinati F Marino D De Giorgio M Baldan A Cantarini M Cursaro C : Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 2006 ; 101 : 524 – 532 . 10.1111/j.1572-0241.2006.00443.x Search in Google Scholar

25. Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M et al.: Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int 2005; 25: 848–853. Tada T Kumada T Toyoda H Kiriyama S Sone Y Tanikawa M : Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma . Liver Int 2005 ; 25 : 848 – 853 . 10.1111/j.1478-3231.2005.01111.x15998436 Search in Google Scholar

26. Okuda H, Saito A, Shiratori K, Yamamoto M, Takasaki K, Nakano M: Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol 2005; 20: 759–764. Okuda H Saito A Shiratori K Yamamoto M Takasaki K Nakano M : Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3 . J Gastroenterol Hepatol 2005 ; 20 : 759 – 764 . 10.1111/j.1440-1746.2005.03773.x15853991 Search in Google Scholar

27. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M et al.: Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 2002; 17: 772–778. Okuda H Nakanishi T Takatsu K Saito A Hayashi N Yamamoto M : Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone . J Gastroenterol Hepatol 2002 ; 17 : 772 – 778 . 10.1046/j.1440-1746.2002.02806.x12121507 Search in Google Scholar

28. Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW et al.: CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9: 161–167. Yu NC Chaudhari V Raman SS Lassman C Tong MJ Busuttil RW : CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis . Clin Gastroenterol Hepatol 2011 ; 9 : 161 – 167 . 10.1016/j.cgh.2010.09.01720920597 Search in Google Scholar

29. Lim S, Kim YK, Park HJ, Lee WJ, Choi D, Park MJ: Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T. J Magn Reson Imaging 2014; 39: 1238–1245. Lim S Kim YK Park HJ Lee WJ Choi D Park MJ : Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T . J Magn Reson Imaging 2014 ; 39 : 1238 – 1245 . 10.1002/jmri.2426524136725 Search in Google Scholar

30. Halıloğlu N, Özkavukcu E, Erden A, Erden I: MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi. Turk J Gastroenterol 2011; 22: 158–164. Halıloğlu N Özkavukcu E Erden A Erden I : MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi . Turk J Gastroenterol 2011 ; 22 : 158 – 164 . 10.4318/tjg.2011.018521796552 Search in Google Scholar

31. Park YS, Lee CH, Kim BH, Lee J, Choi JW, Kim KA et al.: Using Gd-EOBDTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis. Magn Reson Imaging 2013; 31: 1137–1142. Park YS Lee CH Kim BH Lee J Choi JW Kim KA : Using Gd-EOBDTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis . Magn Reson Imaging 2013 ; 31 : 1137 – 1142 . 10.1016/j.mri.2013.01.01123688409 Search in Google Scholar

32. Rosenkrantz AB, Lee L, Matza BW, Kim S: Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity. Clin Radiol 2012; 67: e105–111. Rosenkrantz AB Lee L Matza BW Kim S : Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity . Clin Radiol 2012 ; 67 : 105 – 111 . 10.1016/j.crad.2012.08.01923026725 Search in Google Scholar

33. Choi JY, Lee JM, Sirlin CB: CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 2014; 273: 30–50. Choi JY Lee JM Sirlin CB : CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features . Radiology 2014 ; 273 : 30 – 50 . 10.1148/radiol.14132362426377025247563 Search in Google Scholar

34. Willatt JM, Hussain HK, Adusumilli S, Marrero JA: MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008; 247: 311–130. Willatt JM Hussain HK Adusumilli S Marrero JA : MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies . Radiology 2008 ; 247 : 311 – 130 . 10.1148/radiol.247206133118430871 Search in Google Scholar

35. Dodd GD 3rd, Memel DS, Baron RL, Eichner L, Santiguida LA: Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol 1995; 165: 573–577. Dodd GD 3rd Memel DS Baron RL Eichner L Santiguida LA : Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol 1995 ; 165 : 573 – 577 . 10.2214/ajr.165.3.76454737645473 Search in Google Scholar

36. Margini C, Berzigotti A: Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis 2017; 49: 113–120. Margini C Berzigotti A : Portal vein thrombosis: The role of imaging in the clinical setting . Dig Liver Dis 2017 ; 49 : 113 – 120 . 10.1016/j.dld.2016.11.01327965037 Search in Google Scholar

37. Tublin ME, Dodd GD 3rd, Baron RL: Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 1997; 168: 719–723. Tublin ME Dodd GD 3rd Baron RL : Benign and malignant portal vein thrombosis: differentiation by CT characteristics . AJR Am J Roentgenol 1997 ; 168 : 719 – 723 . 10.2214/ajr.168.3.90575229057522 Search in Google Scholar

38. Raza SA, Jang HJ, Kim TK: Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. Abdom Imaging 2014; 39: 153–161. Raza SA Jang HJ Kim TK : Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound . Abdom Imaging 2014 ; 39 : 153 – 161 . 10.1007/s00261-013-0034-424002440 Search in Google Scholar

39. Tarantino L, Ambrosino P, Di Minno MN: Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma. World J Gastroenterol 2015; 21: 9457–9460. Tarantino L Ambrosino P Di Minno MN : Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma . World J Gastroenterol 2015 ; 21 : 9457 – 9460 . 10.3748/wjg.v21.i32.9457454810626327753 Search in Google Scholar

40. Shah ZK, McKernan MG, Hahn PF, Sahani DV: Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesions. AJR Am J Roentgenol 2007; 188: 1320–1323. Shah ZK McKernan MG Hahn PF Sahani DV : Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesions . AJR Am J Roentgenol 2007 ; 188 : 1320 – 1323 . 10.2214/AJR.06.013417449777 Search in Google Scholar

41. Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV: Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 2010; 254: 154–162. Catalano OA Choy G Zhu A Hahn PF Sahani DV : Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging . Radiology 2010 ; 254 : 154 – 162 . 10.1148/radiol.0909030420032150 Search in Google Scholar

42. Brancatelli G, Baron RL, Federle MP, Sparacia G, Pealer K: Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. AJR Am J Roentgenol 2009; 192: 1341–1347. Brancatelli G Baron RL Federle MP Sparacia G Pealer K : Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT . AJR Am J Roentgenol 2009 ; 192 : 1341 – 1347 . 10.2214/AJR.07.278219380559 Search in Google Scholar

43. Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Miller WJ, Campbell WL et al.: Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993; 188: 31–35. Ohtomo K Baron RL Dodd GD 3rd Federle MP Miller WJ Campbell WL : Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT . Radiology 1993 ; 188 : 31 – 35 . 10.1148/radiology.188.1.85113168511316 Search in Google Scholar

44. Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Ohtomo Y, Confer SR: Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993; 189: 871–874. Ohtomo K Baron RL Dodd GD 3rd Federle MP Ohtomo Y Confer SR : Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging . Radiology 1993 ; 189 : 871 – 874 . 10.1148/radiology.189.3.82347188234718 Search in Google Scholar

45. Pokharel SS, Macura KJ, Kamel IR, Zaheer A. Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis. Radiographics 2013; 33: 681–702. Pokharel SS Macura KJ Kamel IR Zaheer A. Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis . Radiographics 2013 ; 33 : 681 – 702 . 10.1148/rg.333125068 Search in Google Scholar

46. Mortelé KJ, Segatto E, Ros PR: The infected liver: radiologic-pathologic correlation. Radiographics 2004; 24: 937–955. Mortelé KJ Segatto E Ros PR : The infected liver: radiologic-pathologic correlation . Radiographics 2004 ; 24 : 937 – 955 . 10.1148/rg.244035719 Search in Google Scholar

47. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC et al.: Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 2009; 29: 683–700. Chung YE Kim MJ Park YN Choi JY Pyo JY Kim YC : Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation . Radiographics 2009 ; 29 : 683 – 700 . 10.1148/rg.293085729 Search in Google Scholar

48. Lee WJ, Lim HK, Jang KM, Kim SH, Lee SJ, Lim JH et al.: Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 2001; 21: S97–S116. Lee WJ Lim HK Jang KM Kim SH Lee SJ Lim JH : Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses . Radiographics 2001 ; 21 : S97 – S116 . 10.1148/radiographics.21.suppl_1.g01oc12s97 Search in Google Scholar

49. Shim M, Yang TY, Cho NG, Woo A, Kim E, Park K et al.: Hepatic infarction caused by portal vein thrombophlebitis misdiagnosed as infiltrative hepatic malignancy with neoplastic thrombus. Korean J Gastroenterol 2016; 68: 156–160. Shim M Yang TY Cho NG Woo A Kim E Park K : Hepatic infarction caused by portal vein thrombophlebitis misdiagnosed as infiltrative hepatic malignancy with neoplastic thrombus . Korean J Gastroenterol 2016 ; 68 : 156 – 160 . 10.4166/kjg.2016.68.3.156 Search in Google Scholar

50. Jüngst C, Kramer J, Schneider G, Lammert F, Zimmer V: Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration. Ann Hepatol 2013; 12: 834–836. Jüngst C Kramer J Schneider G Lammert F Zimmer V : Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration . Ann Hepatol 2013 ; 12 : 834 – 836 . 10.1016/S1665-2681(19)31329-8 Search in Google Scholar

51. Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME: CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 1994; 163: 1385–1388. Young ST Paulson EK Washington K Gulliver DJ Vredenburgh JJ Baker ME : CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis . AJR Am J Roentgenol 1994 ; 163 : 1385 – 1388 . 10.2214/ajr.163.6.79927347992734 Search in Google Scholar

52. Jha P, Poder L, Wang ZJ, Westphalen AC, Yeh BM, Coakley FV: Radiologic mimics of cirrhosis. AJR Am J Roentgenol 2010; 194: 993–999. Jha P Poder L Wang ZJ Westphalen AC Yeh BM Coakley FV : Radiologic mimics of cirrhosis . AJR Am J Roentgenol 2010 ; 194 : 993 – 999 . 10.2214/AJR.09.340920308502 Search in Google Scholar

53. Ochiai T, Sonoyama T, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C et al.: Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol 2004; 130: 197–202. Ochiai T Sonoyama T Ichikawa D Fujiwara H Okamoto K Sakakura C : Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis . J Cancer Res Clin Oncol 2004 ; 130 : 197 – 202 . 10.1007/s00432-003-0533-814770307 Search in Google Scholar

54. Lopez RR Jr., Pan SH, Hoffman AL, Ramirez C, Rojter SE, Ramos H et al.: Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. Arch Surg 2002; 137: 653–657; discussion 657–658. Lopez RR Jr. Pan SH Hoffman AL Ramirez C Rojter SE Ramos H : Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma . Arch Surg 2002 ; 137 : 653 – 657 ; discussion 657–658 . 10.1001/archsurg.137.6.65312049535 Search in Google Scholar

55. Jang ES, Yoon JH, Chung JW, Cho EJ, Yu SJ, Lee JH et al.: Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization. J Cancer Res Clin Oncol 2013; 139: 635–643. Jang ES Yoon JH Chung JW Cho EJ Yu SJ Lee JH : Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization . J Cancer Res Clin Oncol 2013 ; 139 : 635 – 643 . 10.1007/s00432-012-1364-223283527 Search in Google Scholar

56. Kim SB: Diffuse infiltrative hepatocellular carcinoma with portal vein tumor thrombosis completely cured by transcatheter arterial chemoembolization: case report with 8-year follow-up. Case Rep Gastroenterol 2016; 10: 623–628. Kim SB : Diffuse infiltrative hepatocellular carcinoma with portal vein tumor thrombosis completely cured by transcatheter arterial chemoembolization: case report with 8-year follow-up . Case Rep Gastroenterol 2016 ; 10 : 623 – 628 . 10.1159/000452208512157227920652 Search in Google Scholar

57. Bruix J, Sherman M, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020–1022. Bruix J Sherman M , American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: an update . Hepatology 2011 ; 53 : 1020 – 1022 . 10.1002/hep.24199308499121374666 Search in Google Scholar

58. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al.: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378–390. Llovet JM Ricci S Mazzaferro V Hilgard P Gane E Blanc JF : Sorafenib in advanced hepatocellular carcinoma . N Engl J Med 2008 ; 359 : 378 – 390 . 10.1056/NEJMoa070885718650514 Search in Google Scholar

59. Kim HY, Park JW, Nam BH, Kim HK, Choi JI, Kim TH et al.: Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments. J Gastroenterol Hepatol 2011; 26: 1612–1618. Kim HY Park JW Nam BH Kim HK Choi JI Kim TH : Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments . J Gastroenterol Hepatol 2011 ; 26 : 1612 – 1618 . 10.1111/j.1440-1746.2011.06751.x21517968 Search in Google Scholar

60. Mehta N, Fidelman N, Sarkar M, Yao FY: Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol 2013; 11: 572–578. Mehta N Fidelman N Sarkar M Yao FY : Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma . Clin Gastroenterol Hepatol 2013 ; 11 : 572 – 578 . 10.1016/j.cgh.2012.12.030405289123333661 Search in Google Scholar

61. Endo Y, Miyamoto M, Koujima T, Watanabe Y, Kawai T, Toda K et al.: [A case of advanced hepatocellular carcinoma with portal vein invasion successfully treated by sorafenib]. Gan To Kagaku Ryoho 2012; 39: 963–965. Endo Y Miyamoto M Koujima T Watanabe Y Kawai T Toda K : [A case of advanced hepatocellular carcinoma with portal vein invasion successfully treated by sorafenib] . Gan To Kagaku Ryoho 2012 ; 39 : 963 – 965 . Search in Google Scholar

62. Ray EM, Sanoff HK: Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions. J Hepatocell Carcinoma 2017; 4: 131–138. Ray EM Sanoff HK : Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions . J Hepatocell Carcinoma 2017 ; 4 : 131 – 138 . 10.2147/JHC.S124366568745329184856 Search in Google Scholar

63. Marino D, Zichi C, Audisio M, Sperti E, Di Maio M: Second-line treatment options in hepatocellular carcinoma. Drugs Context 2019; 8: 212577. Marino D Zichi C Audisio M Sperti E Di Maio M : Second-line treatment options in hepatocellular carcinoma . Drugs Context 2019 ; 8 : 212577 . 10.7573/dic.212577646974531024634 Search in Google Scholar

64. Personeni N, Pressiani T, Rimassa L: Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib. Future Oncol 2019; 15: 2449–2462. Personeni N Pressiani T Rimassa L : Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib . Future Oncol 2019 ; 15 : 2449 – 2462 . 10.2217/fon-2019-002631204849 Search in Google Scholar

65. Hsiao P, Hsieh KC, Chen YS, Hsu CC, Lo GH, Li YC et al.: Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma. Medicine (Baltimore) 2019; 98: e16074. Hsiao P Hsieh KC Chen YS Hsu CC Lo GH Li YC : Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma . Medicine (Baltimore) 2019 ; 98 : 16074 . 10.1097/MD.0000000000016074663696431232945 Search in Google Scholar

66. Reghupaty SC, Sarkar D: Current status of gene therapy in hepatocellular carcinoma. Cancers (Basel) 2019; 11. Reghupaty SC Sarkar D : Current status of gene therapy in hepatocellular carcinoma . Cancers (Basel) 2019 ; 11 . 10.3390/cancers11091265677084331466358 Search in Google Scholar